Back to catalog
Single Mitochondrial 5mg Vial

SS-31 (Elamipretide) dosing guide

SS-31 (Elamipretide/Bendavia) is a mitochondria-targeted tetrapeptide that binds to cardiolipin in the inner mitochondrial membrane. It optimizes mitochondrial function, reduces oxidative stress, and has potential applications in aging, heart failure, and mitochondrial diseases.

Quickstart Highlights

  • Dosage: 10-40mg
  • Frequency: Daily or as needed
  • Administration: Subcutaneous injection or IV
  • Cycle length: 4-12 weeks or ongoing

Dosing Plan

Weeks Dose Units
Weeks 1–2 (Assessment) 10mg once daily 40 units (0.4mL)
Weeks 3–8 (Standard) 20mg once daily 80 units (0.8mL) or split vials
Clinical plan 40mg daily IV or SC as directed
Anti-Aging Maintenance 10-20mg 3x weekly Subcutaneous

How to mix

2mL BAC water per 5mg vial = 2.5mg/mL (2,500mcg/mL)

  1. Draw 2.0mL bacteriostatic water with a sterile syringe.
  2. Inject slowly down the vial wall to prevent foaming.
  3. Gently swirl until powder is completely dissolved. Do not shake.
  4. Label with date. Concentration = 2.5mg/mL (2,500mcg/mL).
  5. Refrigerate at 2–8°C. Use within 4 weeks of reconstitution.

Syringe Math Reference

  • 5mg vial with 2mL BAC water = 2.5mg/mL = 2,500mcg/mL
  • 10mg dose = 2 vials (entire contents of each) or 1 × 10mg vial with 2mL = 5mg/mL
  • 20mg dose = 4 vials at 5mg each
  • For 10mg vials: 2mL BAC water = 5mg/mL; 10mg = 2mL (full vial)
  • For 5mg vials: 2mL BAC water = 2.5mg/mL; 10mg = 4mL (2 full vials)

What you'll need

SS-31 Vials (5mg)

  • 4 weeks (10mg/day) 8 vials
  • 8 weeks (20mg/day) 32 vials
  • 12 weeks (20mg 3x/wk) 14-16 vials

Insulin Syringes (U-100, 1mL)

  • 4 weeks 30 syringes
  • 8 weeks 60 syringes
  • 12 weeks 40 syringes

Bacteriostatic Water (10mL)

  • 4 weeks 2 bottles
  • 8 weeks 4 bottles
  • 12 weeks 3 bottles

Alcohol Swabs

  • 4 weeks 1 × 100-count box
  • 8 weeks 2 × 100-count boxes
  • 12 weeks 1 × 100-count box

How This Works

SS-31 is a cell-permeable tetrapeptide that concentrates 1000-5000x in mitochondria due to its affinity for cardiolipin, a phospholipid in the inner mitochondrial membrane essential for electron transport chain function. By stabilizing cardiolipin and optimizing cristae structure, SS-31 improves ATP production, reduces electron leak and ROS generation, and protects against mitochondrial dysfunction. This has systemic effects on aging, cardiac function, and energy metabolism.

Mechanism of Action

How SS-31 Works in Your Body

1

Peptide Administered

Enters the bloodstream via injection

2

Receptor Binding

Finds and activates its target receptor

3

Signal Cascade

Triggers a chain of cellular responses

4

Biological Effect

The body produces the desired outcome

Receptor Binding

How peptides activate cellular receptors

  1. Approach
  2. Bind
  3. Activate

Benefits & Side Effects

Potential Benefits

  • Improved mitochondrial function
  • Increased cellular energy (ATP)
  • Reduced oxidative stress
  • Enhanced cardiac function
  • Improved exercise tolerance
  • Potential anti-aging effects

Potential Side Effects

  • Generally well-tolerated in trials
  • Injection site reactions
  • Headache (occasional)
  • Nausea (rare)

How to store it

  • Lyophilized: Store at -20°C for long-term; refrigerated (2–8°C) for short-term.
  • Reconstituted: Refrigerate at 2–8°C; use within 3-4 weeks.
  • Protect from light and excessive heat.
  • Do not freeze reconstituted solution.
  • SS-31 is relatively stable but avoid repeated freeze-thaw cycles.

Good to know

  • Mitochondria-targeted tetrapeptide.
  • Binds to cardiolipin in inner mitochondrial membrane.
  • In clinical trials for Barth syndrome, heart failure, mitochondrial myopathy.
  • May improve exercise tolerance and cardiac function.
  • One of the most studied anti-aging peptides.
  • Reduces mitochondrial ROS production.
  • Can cross cell membranes due to cationic charge.

Community Insights

Summarised from 1 source

SS-31 (Elamipretide) is discussed by the Reddit community primarily for its potential benefits related to mitochondrial function, energy, and cognitive improvements. Users report a wide range of positive effects, from increased athletic performance and recovery to relief from chronic fatigue and pain. There is a general sentiment that SS-31 may offer significant therapeutic potential, particularly for age-related decline and conditions involving mitochondrial dysfunction. Some users are surprised by the extent of its positive impact, while others express concerns about its accessibility and long-term effects. The discussions highlight a strong interest in its off-label use given its promising anecdotal results, despite a lack of extensive human clinical trial data for many of these applications.

Key Benefits

  • Mitochondrial function improvement
  • Increased energy and reduced fatigue
  • Enhanced cognitive function (focus, memory)
  • Improved athletic performance and recovery
  • Anti-aging effects
  • Pain relief (especially chronic pain)

Common Dosages Reported

  • 1mg daily
  • 5mg daily

Side Effects Mentioned

  • Potential for withdrawal effects (e.g., rebound fatigue) upon discontinuation

What people are saying

"I can lift more, focus more, and do more in a day without feeling tired."
"It feels like my body is 10-15 years younger."
"Significantly improved my chronic pain and fatigue."
"My brain fog has lifted, and my memory is sharper."
"Wish I had known about this sooner."

Reviews & Discussion

Real experiences shared by the community — not medical advice.

Your rating:

Auto-moderated. Not medical advice.

Potency and Practical Comparison to Other Antioxidants

In a discussion comparing SS-31 to other antioxidants like C60, a user discussed its high potency in preventing mitochondrial swelling. While they found the research promising, they noted the practical difficulties in obtaining and dosing the peptide for personal use.

Mitochondrial Targeting and ROS Reduction

A user noted that SS-31 effectively targets the inner mitochondrial membrane to reduce reactive oxygen species (ROS) without affecting normal signaling. They highlighted its potential for treating conditions like ischemia-reperfusion injury and heart failure based on available research.

FDA Progress and Cardiolipin Stabilization

A user expressed optimism regarding elamipretide (SS-31) following its progression in FDA clinical trials for rare mitochondrial diseases. They emphasized its unique mechanism of stabilizing cardiolipin to improve mitochondrial energetics.

SS-31 Potential for Sarcopenia Treatment

A forum moderator shared an abstract discussing the use of SS-31 (Elamipretide) as a potential pharmacotherapy for sarcopenia. The research indicates that while SS-31 shows promising findings in treating progressive muscle mass decline and organ failure, it has not yet received official approval for this indication.

Positive feedback for kidney repair

A member described SS-31 as one of the few peptides they 'love.' They highlighted its specific utility for kidney repair, noting that such benefits are rare among other substances.

Synergistic effects with MOTS-c

A user reported taking 3 mg of SS-31 daily in combination with 2 mg of MOTS-c. They noted that the two peptides work synergistically and that the effects of MOTS-c feel significantly stronger and more consistent when paired with SS-31 than when taken alone.

Increased Stamina and Energy after 20-Day Course

A user shared that after completing a 20-day course of SS-31 at 5mg daily, they experienced a significant increase in energy levels and successfully navigated a challenging period involving heavy travel and physical activity. They felt the peptide provided a foundational improvement in their overall stamina.

Significant Improvement in Chronic Fatigue and POTS

A user with multiple chronic conditions, including chronic fatigue syndrome, MCAS, and POTS, reported that SS-31 significantly improved their baseline health. They described the peptide as helping them more than other treatments, likely by addressing mitochondrial dysfunction associated with their illnesses.

Mitochondrial Pre-treatment Success

An individual reported that SS-31 effectively 'cleans up' mitochondrial damage and prepares the body for subsequent cycles of MOTS-c. They noted that it is particularly effective for those with existing mitochondrial issues to ensure better outcomes with biogenesis-focused peptides.

Mitochondrial ROS Prevention via SS-31

A user noted that SS-31 effectively prevents the formation of reactive oxygen species (ROS) at their source by targeting the mitochondrial inner membrane and cardiolipin. They highlighted its potential for reducing oxidative stress more efficiently than traditional antioxidants that only scout for ROS after they have been produced.

SS-31 and Mitochondrial Efficiency

A user discussed the mechanism of SS-31, explaining that it serves as a potent peptide that prevents electron leakage from the mitochondrial electron transport chain. They compared its function to other mitochondrial-targeted substances, emphasizing its ability to maintain mitochondrial efficiency and reduce age-related oxidative damage.

Mitochondrial Targeting for Sarcopenia

In a thread discussing sarcopenia therapies, it was noted that SS-31 (Elamipretide) has shown promising findings in clinical research for muscle-related disorders. While noted as an effective mitochondrial targeting agent, the forum contributor emphasized that it has not yet received official approval for the treatment of sarcopenia.

Positive for kidney repair

A member highly praised SS-31, stating it is one of the few peptides they love. They specifically highlighted its utility for kidney repair, noting that such benefits are rare.

Synergistic effects with MOTS-c

A user reported taking 3 mg of SS-31 daily in combination with 2 mg of MOTS-c. They noted that the two peptides work synergistically, making the effects of MOTS-c feel stronger and more consistent than when it is taken alone.

Significant relief for chronic fatigue and MCAS symptoms

A user with chronic fatigue, MCAS, and POTS reported significant improvements after starting SS-31. They noted a substantial increase in energy levels and a reduction in systemic symptoms, leading them to describe the peptide as highly effective for their complex health issues.

Improved stamina when used as a primer for MOTS-c

A participant in the discussion shared that using SS-31 prior to a cycle of MOTS-c helped prepare their mitochondria, leading to better overall energy outcomes. They experienced improved stamina and felt the sequence was essential for maximizing the benefits of mitochondrial biogenesis.

Reduction in brain fog and inflammation at 4mg daily

A user reported using SS-31 at a dosage of 4mg daily for 20 days and observed a noticeable reduction in brain fog and inflammatory markers. While the effects were subtle at first, they felt a cumulative improvement in cognitive clarity and physical recovery.

Auto-moderated. Not medical advice.

No discussion yet — be the first.

Auto-moderated. Not medical advice.

No notes yet — be the first.